SCHEMBL27364556

SCHEMBL27364556

CC(C)(C)OC(=O)Nc1cc(-c2ccc3cc(O)ccc3n2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ ESR1 P03372 1/20 0.45
▸ ESR2 Q92731 1/20 0.45
▸ AAK1 Q2M2I8 13/20 0.43
▸ DAPK1 P53355 3/20 0.43
▸ MKNK2 Q9HBH9 3/20 0.43
▸ BMP2K Q9NSY1 3/20 0.43
▸ MKNK1 Q9BUB5 2/20 0.43
▸ MYLK2 Q9H1R3 2/20 0.43
▸ DAPK3 O43293 2/20 0.43
▸ JAK2 O60674 2/20 0.43
▸ HIPK4 Q8NE63 2/20 0.43
▸ GAK O14976 2/20 0.43
▸ CIT O14578 1/20 0.43
▸ MAP2K1 Q02750 1/20 0.43
▸ PKN2 Q16513 1/20 0.43
▸ TLK2 Q86UE8 1/20 0.43
▸ STK39 Q9UEW8 1/20 0.43
▸ TLK1 Q9UKI8 1/20 0.43
▸ HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10049511 0.86 ESR2 (0.49) ESR1ESR2GSK3BDYRK1A
SCHEMBL27364663 0.82 IRAK4 (0.42) IRAK4AAK1DAPK1MKNK2BMP2K
SCHEMBL27364340 0.79 ESR1 (0.56) ESR1ESR2AAK1
SCHEMBL1192656 0.78 ATR (0.50) IRAK4AAK1JAK2TGFBR1GSK3B
SCHEMBL30953487 0.78 ATR (0.50) IRAK4AAK1JAK2TGFBR1GSK3B
SCHEMBL27364664 0.78 IRAK4 (0.41) IRAK4AAK1DAPK1MKNK2BMP2K
SCHEMBL27403784 0.76 IRAK4 (0.54) IRAK4AAK1DAPK1MKNK2BMP2K
SCHEMBL1289516 0.76 ESR1 (0.53) ESR1ESR2
SCHEMBL21672291 0.75 IRAK4 (0.53) IRAK4AAK1DAPK1MKNK2BMP2K
SCHEMBL16464884 0.75 IRAK4 (0.61) IRAK4AAK1DAPK1MKNK2BMP2K

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024049976-A1 N-METHYL-4-(QUINOLIN-2-YL)PYRIDIN-2-AMINE COMPOUNDS ABBVIE INC. (US) 2024-03-07 — — WO disclosed
Send feedback